EP3226841
KRABBAMEINSLYF SAMSETNING
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.12.2015EP published:
9.10.2024EP application number:
15817641.2
EP translation filed:
23.1.2025Grant published:
15.2.2025EPO information:
European Patent Register
Max expiry date:
2.12.2035Expiry date:
2.12.2026Next due date:
31.12.2026
Title in English:
ANTICANCER COMPOSITIONSLanguage of the patent:
English
Timeline
Today
3.12.2015EP application
9.10.2024EP Publication
23.1.2025Translation submitted
15.2.2025Registration published
2.12.2026Expires
Owner
Name:
Aragon Pharmaceuticals, Inc.Address:
10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024, US
Inventor
Name:
HESTER, Dennis MartinAddress:
San Diego, California 92130, US
Name:
VAUGHN, Jason MichaelAddress:
High Point, North Carolina 27265, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
14196594Date:
5.12.2014Country:
EP
Classification
Categories:
A61K 31/4184, A61P 35/00, A61K 9/14, A61K 9/20
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 27.12.2024
Expires: 2.12.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.12.2025
Expires: 2.12.2026
Payer: Árnason Faktor ehf.